Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
OPEN BMC psychiatry | 10 Feb 2017
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth, SE Stallknecht, K Leth-Møller, M Iversen, MB Banke, IJ Petersen, SL Klingenberg, J Krogh, SE Ebert, A Timm, J Lindschou and C Gluud
The evidence on selective serotonin reuptake inhibitors (SSRIs) for major depressive disorder is unclear.
* Data courtesy of Altmetric.com